- Home
- UPLD vs QNCX Comparison
UPLD vs QNCX Comparison
Compare UPLD & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPLD
- QNCX
- Stock Information
- Founded
- UPLD 2010
- QNCX 2012
- Country
- UPLD United States
- QNCX United States
- Employees
- UPLD N/A
- QNCX N/A
- Industry
- UPLD Computer Software: Prepackaged Software
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UPLD Technology
- QNCX Health Care
- Exchange
- UPLD Nasdaq
- QNCX Nasdaq
- Market Cap
- UPLD 51.0M
- QNCX 47.7M
- IPO Year
- UPLD 2014
- QNCX 2019
- Fundamental
- Price
- UPLD $1.85
- QNCX $1.65
- Analyst Decision
- UPLD Hold
- QNCX Strong Buy
- Analyst Count
- UPLD 1
- QNCX 6
- Target Price
- UPLD N/A
- QNCX $8.17
- AVG Volume (30 Days)
- UPLD 249.8K
- QNCX 192.0K
- Earning Date
- UPLD 07-31-2025
- QNCX 08-19-2025
- Dividend Yield
- UPLD N/A
- QNCX N/A
- EPS Growth
- UPLD N/A
- QNCX N/A
- EPS
- UPLD N/A
- QNCX N/A
- Revenue
- UPLD $251,757,000.00
- QNCX N/A
- Revenue This Year
- UPLD N/A
- QNCX N/A
- Revenue Next Year
- UPLD N/A
- QNCX N/A
- P/E Ratio
- UPLD N/A
- QNCX N/A
- Revenue Growth
- UPLD N/A
- QNCX N/A
- 52 Week Low
- UPLD $1.69
- QNCX $0.51
- 52 Week High
- UPLD $5.64
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- UPLD 43.48
- QNCX 47.34
- Support Level
- UPLD $1.98
- QNCX $1.55
- Resistance Level
- UPLD $2.52
- QNCX $1.75
- Average True Range (ATR)
- UPLD 0.26
- QNCX 0.11
- MACD
- UPLD -0.03
- QNCX -0.03
- Stochastic Oscillator
- UPLD 2.80
- QNCX 20.00
About UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.